Comparison of Spectrophotometric and Fluorimetric Methods in Evaluation of Biotinidase Deficiency
- PMID: 28356871
- PMCID: PMC5346788
- DOI: 10.1515/jomb-2016-0004
Comparison of Spectrophotometric and Fluorimetric Methods in Evaluation of Biotinidase Deficiency
Abstract
Background: Biotin, a water-soluble vitamin, is used as a co-factor by enzymes involved in carboxylation reactions. Biotinidase (BTD) catalyzes the recycling of biotin from endogenous and dietary sources. Biotinidase deficiency (BD) is an autosomal recessively inherited disorder of biotin recycling that is associated with neurologic and cutaneous consequences when untreated. The aim of the study was to compare the results of spectrophotometric and fluorimetric methods, as well as to evaluate the advantages and disadvantages of both methods in current research practices.
Methods: Study group was chosen among the BD suspected newborn, children and parents (n = 52) who applied to Hacettepe University Pediatric Metabolism Unit.
Results: BTD activity is stable for 2 hours at room temperature and at 4 °C, and for 4 months at -20 °C and -80 °C. Genetic and clinical results showed that 25% of the total number of patients had complete BD which was treated with 10 mg/day biotin, while 15.38% of the patients had partial BD, and they were prescribed biotin 5 mg/day. The area under the ROC curve was 0.960±0.25 and 0.927± 0.41 for the fluorimetric and spectrophotometric method, respectively. Fluorimetric method showed 100% sensitivity and 97% specificity, whereas spectrophotometric method showed 90.5% sensitivity and 93.7% specificity.
Conclusions: Fluorimetric method is superior to the spectrophotometric method due to higher sensitivity and specificity.
Uvod: Enzimi uključeni u reakcije karboksilacije koriste biotin, vitamin rastvorljiv u vodi, kao kofaktor. Biotinidaza (BTD) katališe recikliranje biotina iz endogenih izvora i iz ishrane. Nedostatak biotinidaze (NB) predstavlja autozomni recesivni nasledni poremećaj recikliranja biotina koji se u slučaju nelečenja povezuje s neurološkim i kožnim posledicama. Cilj ove studije bio je da se uporede rezultati spektrofotometrijskog i fluorimetrijskog metoda, kao i da se procene prednosti i mane oba ova metoda u današnjoj istraživačkoj praksi.
Metode: Studijsku grupu smo izabrali između novorođenčadi, dece i roditelja (n=52) sa sumnjom na NB koji su se javili Pedijatrijskom odeljenju za metabolizam Univerziteta Hacettepe.
Rezultati: Aktivnost BTD stabilna je 2 sata na sobnoj temperaturi i na 4 °C, a 4 meseca na –20 °C i –80 °C. Genetski i klinički rezultati pokazuju da 25% ukupnog broja obolelih ima potpuni NB, koji je tretiran sa 10 mg biotina dnevno, dok 15,38% obolelih ima delimični NB, tretiran sa 5 mg biotina dnevno. Oblast ispod ROC krive iznosila je 0,960±0,25 za fluorimetrijski, odnosno 0,927±0,41 za spektrofotometrijski metod. Fluorimetrijski metod pokazao je osetljivost od 100% i specifičnost od 97%, dok je spektrofotometrijski metod pokazao osetljivost od 90,5% i specifičnost od 93,7%.
Zaključak: Fluorimetrijski metod je superioran u odnosu na spektrofotometrijski zbog svoje veće osetljivosti i specifičnosti.
Keywords: biotinidase; enzyme deficiency; fluorimetry; spectrophotometry.
Conflict of interest statement
The authors stated that they have no conflicts of interest regarding the publication of this article.
Figures








Similar articles
-
Evaluation of clinical, laboratory, and molecular genetic features of patients with biotinidase deficiency.Eur J Pediatr. 2024 Mar;183(3):1341-1351. doi: 10.1007/s00431-023-05376-4. Epub 2023 Dec 23. Eur J Pediatr. 2024. PMID: 38141137
-
Single center experience of biotinidase deficiency: 259 patients and six novel mutations.J Pediatr Endocrinol Metab. 2018 Aug 28;31(8):917-926. doi: 10.1515/jpem-2018-0148. J Pediatr Endocrinol Metab. 2018. PMID: 29995633 Clinical Trial.
-
High frequency of biotinidase deficiency in Italian population identified by newborn screening.Mol Genet Metab Rep. 2020 Dec 5;25:100689. doi: 10.1016/j.ymgmr.2020.100689. eCollection 2020 Dec. Mol Genet Metab Rep. 2020. PMID: 33312878 Free PMC article.
-
Biotinidase deficiency: "if you have to have an inherited metabolic disease, this is the one to have".Genet Med. 2012 Jun;14(6):565-75. doi: 10.1038/gim.2011.6. Epub 2012 Jan 5. Genet Med. 2012. PMID: 22241090 Review.
-
The neurology of biotinidase deficiency.Mol Genet Metab. 2011 Sep-Oct;104(1-2):27-34. doi: 10.1016/j.ymgme.2011.06.001. Epub 2011 Jun 12. Mol Genet Metab. 2011. PMID: 21696988 Review.
Cited by
-
Recovery of enzyme activity in biotinidase deficient individuals during early childhood.J Inherit Metab Dis. 2022 May;45(3):605-620. doi: 10.1002/jimd.12490. Epub 2022 Mar 3. J Inherit Metab Dis. 2022. PMID: 35195902 Free PMC article.
-
Two novel BTD mutations causing profound biotinidase deficiency in a Chinese patient.Mol Genet Genomic Med. 2021 Feb;9(2):e1591. doi: 10.1002/mgg3.1591. Epub 2021 Jan 16. Mol Genet Genomic Med. 2021. PMID: 33452876 Free PMC article.
-
Evaluation of Renal Function in Alzheimer's Disease and Geriatric Patients: Results from a Turkish Two-center Study.J Med Biochem. 2017 Jan 25;36(1):54-61. doi: 10.1515/jomb-2016-0028. eCollection 2017 Jan. J Med Biochem. 2017. PMID: 28680350 Free PMC article.
-
High Incidence of Partial Biotinidase Deficiency in the First 3 Years of a Regional Newborn Screening Program in Italy.Int J Environ Res Public Health. 2022 Jul 2;19(13):8141. doi: 10.3390/ijerph19138141. Int J Environ Res Public Health. 2022. PMID: 35805799 Free PMC article.
-
Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.Genet Med. 2017 Oct;19(10). doi: 10.1038/gim.2017.84. Epub 2017 Jul 5. Genet Med. 2017. PMID: 28682309
References
-
- Usha D, Ranjan DB. Newborn screening – from Guthrie age to genomic age. J Obstet Gynecol India. 2010;60:210–20.
-
- Tokatli A, Coşkun T, Ozalp I, Günay M. The major presenting symptom in a biotinidase-deficient patient: laryngeal stridor. J Inherit Metab Dis. 1992;15:281–2. - PubMed
-
- Baumgartner ER, Suormala T. Fernandez J, Saudubray JM, van den Berghe G. Inborn Metabolic Diseases. Berlin: Springer; 2000. Biotin-responsive multiple carboxylase deficiency; pp. 276–82.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous